Chinese expert consensus on an innovative patient‐centered approach to diagnosis and treatment of cancer

Author:

Mo Hongnan1ORCID,Zhong Ruiqi12ORCID,Ma Fei1ORCID

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Abstract

AbstractPatient‐centered care (PCC) is an innovative approach to the diagnosis and treatment of malignancy that aims to improve patients' experience during the management of their disease. However, despite growing interest, the concept and specifics of PCC remain unclear. This consensus document addresses this gap by providing a literature review and a clear definition of PCC and outlines its main components as observed in real‐world practice. These components include daytime diagnostic and treatment procedures, in‐hospital and community‐based infusion centers, home‐based diagnostic and treatment services, smart healthcare solutions, and integration of traditional Chinese medicine. This document delves into the implementation of PCC and explores its potential benefits.

Publisher

Wiley

Reference75 articles.

1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants

2. Patient-centredness: a conceptual framework and review of the empirical literature

3. ChenJX. Research on the application of case management mode during the daytime diagnosis and treatment of cancer patients. Presented at: Proceedings of the 5th Shanghai International Nursing Congress; 2022.http://d-wanfangdata-com-cn-s.webvpn.bjmu.doc110.com/conference/ChZDb25mZXJlbmNlTmV3UzIwMjMwOTAxEggxMDY3MDM3NRoIbmF3YjNnZzc%3D

4. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making

5. Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3